Skip to main content

Table 1 Participant characteristics

From: Community acceptability of dolutegravir-based HIV treatment in women: a qualitative study in South Africa and Uganda

  South Africa Uganda
In-depth interviews N = 20 N = 22
Pregnant 15 9
Lactating woman 5 13
Age range
 18–24 years 3 2
  > 24 years 17 20
Education
 Primary 6 10
 Secondary/High school 13 8
 Post-secondary 1 2
Dolutegravir exposure
 Exposed 8 11
 Not exposed 12 11
Participant type
 DolPHIN-2 trial participants 8 10
 Non-trial participants 12 12
Focus group discussions N = 9 N = 6
Gender
 Women 4 (40 participants) 3 (27 participants)
 Men 5 (59 participants) 3 (28 participants)
Age range
 18–24 years 18 10
  > 24 years 81 45
\